IPP Bureau
Syngene revenue from operations up 17 per cent in Q2FY22
By IPP Bureau - October 21, 2021
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
Biocon Biologics’ interchangeable biosimilar insulin Glargine preferred on Express Scripts
By IPP Bureau - October 21, 2021
Express Scripts, a leading pharmacy benefit management organization, will list Viatris labelled biosimilar insulin Glargine as a preferred insulin brand on its National Preferred Formulary (NPF)
HCL Tech and Innovaccer collaborate to scale up digital health transformation
By IPP Bureau - October 20, 2021
By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance
Medtronic announces launch of Open Innovation Platform for APAC
By IPP Bureau - October 20, 2021
The company proposes to invest up to US $ 50 million, over a period of five years, starting from FY22, to support capability development of talent and technology
FDA approves Cyltezo, the first interchangeable biosimilar to Humira
By IPP Bureau - October 20, 2021
Second interchangeable biosimilar product approved by agency
NIH grants in-principle accreditation to Advanced Enzymes supplements
By IPP Bureau - October 20, 2021
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
AstraZeneca India opens clinical data and insights division
By IPP Bureau - October 20, 2021
The division is expected to grow to over a 100-member strong team by 2022
Trivitron partners with Diagon-Vanguard to launch its coagulation range in India
By IPP Bureau - October 20, 2021
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
Domestic growth to the fore as US weakness persists: ICICI Direct
By IPP Bureau - October 19, 2021
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
U.S. FDA authorises new saliva sample collection for Covid-19
By IPP Bureau - October 19, 2021
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
Pharma exports continue to climb in H1FY22
By IPP Bureau - October 19, 2021
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
Alcon announces launch of AcrySof IQ Vivity in India,
By IPP Bureau - October 19, 2021
It is the first presbyopia-correcting lens implant for cataract surgery
Dr Reddy’s Labs announces U.S. FDA approval for Lenalidomide capsules
By IPP Bureau - October 19, 2021
The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg
MSN Labs launches drug for diabetes management
By IPP Bureau - October 19, 2021
The company claims that its Empagliflozin tablets are the most affordable in India
Vertex’s stem cell therapy for Type 1 diabetes reduced daily insulin requirement by 91 %
By IPP Bureau - October 19, 2021
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
